These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 12241952)

  • 21. Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
    Milne RL; Osorio A; Ramón y Cajal T; Baiget M; Lasa A; Diaz-Rubio E; de la Hoya M; Caldés T; Teulé A; Lázaro C; Blanco I; Balmaña J; Sánchez-Ollé G; Vega A; Blanco A; Chirivella I; Esteban Cardeñosa E; Durán M; Velasco E; Martínez de Dueñas E; Tejada MI; Miramar MD; Calvo MT; Guillén-Ponce C; Salazar R; San Román C; Urioste M; Benítez J
    Breast Cancer Res Treat; 2010 Jan; 119(1):221-32. PubMed ID: 19370414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study.
    Hopper JL; Southey MC; Dite GS; Jolley DJ; Giles GG; McCredie MR; Easton DF; Venter DJ
    Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):741-7. PubMed ID: 10498392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
    Rennert G; Bisland-Naggan S; Barnett-Griness O; Bar-Joseph N; Zhang S; Rennert HS; Narod SA
    N Engl J Med; 2007 Jul; 357(2):115-23. PubMed ID: 17625123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.
    Sinclair CS; Adem C; Naderi A; Soderberg CL; Johnson M; Wu K; Wadum L; Couch VL; Sellers TA; Schaid D; Slezak J; Fredericksen Z; Ingle JN; Hartmann L; Jenkins RB; Couch FJ
    Cancer Res; 2002 Jul; 62(13):3587-91. PubMed ID: 12097257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential contributions of BRCA1 and BRCA2 to early-onset breast cancer.
    Krainer M; Silva-Arrieta S; FitzGerald MG; Shimada A; Ishioka C; Kanamaru R; MacDonald DJ; Unsal H; Finkelstein DM; Bowcock A; Isselbacher KJ; Haber DA
    N Engl J Med; 1997 May; 336(20):1416-21. PubMed ID: 9145678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of BRCA1 and BRCA2 germline mutations to the incidence of early-onset breast cancer in Cyprus.
    Loizidou M; Marcou Y; Anastasiadou V; Newbold R; Hadjisavvas A; Kyriacou K
    Clin Genet; 2007 Feb; 71(2):165-70. PubMed ID: 17250666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients.
    Cecener G; Egeli U; Tunca B; Erturk E; Ak S; Gokgoz S; Tasdelen I; Tezcan G; Demirdogen E; Bayram N; Avci N; Evrensel T
    Cancer Invest; 2014 Oct; 32(8):375-87. PubMed ID: 24884828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
    Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
    Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiotherapy for breast cancer.
    Kunkler I
    N Engl J Med; 2002 Mar; 346(11):862-4. PubMed ID: 11898812
    [No Abstract]   [Full Text] [Related]  

  • 30. Double heterozygosity for mutations in BRCA1 and BRCA2 in German breast cancer patients: implications on test strategies and clinical management.
    Heidemann S; Fischer C; Engel C; Fischer B; Harder L; Schlegelberger B; Niederacher D; Goecke TO; Doelken SC; Dikow N; Jonat W; Morlot S; Schmutzler RC; Arnold NK
    Breast Cancer Res Treat; 2012 Aug; 134(3):1229-39. PubMed ID: 22535016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague area.
    Pohlreich P; Zikan M; Stribrna J; Kleibl Z; Janatova M; Kotlas J; Zidovska J; Novotny J; Petruzelka L; Szabo C; Matous B
    Breast Cancer Res; 2005; 7(5):R728-36. PubMed ID: 16168118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
    Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Investigation of mutations of BRCA1 and BRCA2 genes in 52 breast cancer patients].
    Tereshchenko IV; Béshém VM; Slonimskaia EM; Ponder BA; Férokh PD; Velichko SA; Shagiakhmetova RA
    Vopr Onkol; 2002; 48(1):24-8. PubMed ID: 12101561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives.
    Cao AY; Huang J; Hu Z; Li WF; Ma ZL; Tang LL; Zhang B; Su FX; Zhou J; Di GH; Shen KW; Wu J; Lu JS; Luo JM; Yuan WT; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2009 May; 115(1):51-5. PubMed ID: 18483852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contribution of epigenetic alteration of BRCA1 and BRCA2 genes in breast carcinomas in Tunisian patients.
    Ben Gacem R; Hachana M; Ziadi S; Amara K; Ksia F; Mokni M; Trimeche M
    Cancer Epidemiol; 2012 Apr; 36(2):190-7. PubMed ID: 21978880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormone replacement and breast cancer.
    Castiglione-Gertsch M
    Ann Oncol; 2004; 15 Suppl 4():iv275-7. PubMed ID: 15477320
    [No Abstract]   [Full Text] [Related]  

  • 37. Breast cancer symposium highlights risk, recurrence, and research trials.
    Hampton T
    JAMA; 2012 Jan; 307(4):348-50. PubMed ID: 22274677
    [No Abstract]   [Full Text] [Related]  

  • 38. Using BRCA1 to treat cancer.
    Environ Health Perspect; 1996 Jul; 104(7):686-7. PubMed ID: 8841747
    [No Abstract]   [Full Text] [Related]  

  • 39. Meta-analysis for trials in early breast cancer: a recent update.
    Ann Oncol; 1991 Jan; 2(1):3. PubMed ID: 1826212
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in the treatment of breast cancer.
    Smellie WJ; Sacks NP
    Postgrad Med J; 1994 Apr; 70(822):243-6. PubMed ID: 8183769
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.